What's breaking now, across thousands of outlets.
The agency will now require drug companies making GLP-1 receptor agonist therapies to add safety labels warning that they could cause non-arteritic anterior ischemic optic neuropathy, or NAION.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.
November’s US midterm elections swept Democrats into power in both the House and Senate, marking a shift in congressional leadership on key health policies.
(MedPage Today) -- Every year, we wait on the arrival of this season's annual flu vaccine, patiently biding our time and explaining to our patients that it's coming, any day now, while the…
Differences within breast tumors and between patients are associated with the risk of metastasis and response to endocrine therapy, according to a new doctoral thesis from Karolinska Institutet.
WASHINGTON — Former U.S. president Joe Biden says he is scaling back plans to promote his upcoming memoir as he battles aggressive prostate cancer, acknowledging that the illness sometimes leaves him…
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results…
ANTALYA – The 31st United Nations (UN) climate conference, COP31, got underway on Monday in the Turkish coastal city of Antalya, where some 100,000 people, including more than 90 heads of state and…
